510(k) Report

510(k) · Cleared

Recalled · 2010

Depuy Asr Resurfacing Femoral Heads

K032659510(k) TraditionalCleared Dec 4, 200398-day reviewClass II21 CFR 888.3400Recalls 13

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

DePuy Orthopaedics, Inc. · KXA Prosthesis, Hip, Femoral, Resurfacing

Cleared on Dec 4, 2003 as substantially equivalent to K021799 (Biomet Orthopedics, Inc., 2002) after a 98-day review. Its family tree reaches back 2 generations to 1998. 2 later devices descend from it. It has been recalled 13 times.

Decided
Dec 4, 2003
Review
98 days
Class
Class II
Product code
KXA
Recalls
13
Predicates
2

Its longest line of descent runs back 2 generations to K983452 (1998). 2 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2005: 1 descendant cleared2007: 1 descendant clearedK983452 · Nelson Resurfacing Head · Biomet, Inc. · 1998K021799 · Cemented Femoral Head Resurfing Device · Biomet Orthopedics, Inc. · 20021995200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants K021799 · Cemented Femoral Head Resurfing Device · Biomet Orthopedics, Inc. · 2002K983452 · Nelson Resurfacing Head · Biomet, Inc. · 19980
  1. Root · 2 generations backK983452 Nelson Resurfacing HeadBiomet, Inc. · 1998
  2. 1 generation backK021799 Cemented Femoral Head Resurfing DeviceBiomet Orthopedics, Inc. · 2002
  3. This deviceK032659 Depuy Asr Resurfacing Femoral HeadsDePuy Orthopaedics, Inc. · 2003
  4. Descendant · cites it directly · 1 of its ownK043542 Biopro Tara Femoral Resurfacing ComponentBiopro, Inc. · 2005
  5. Descendant · cites it directly · 0 of its ownK070292 Durom Hip Resurfacing System, Femoral ComponentsZimmer GmbH · 2007 · Recalled

Most influential descendants

Showing 2 of 2 · See all
  • K043542Biopro Tara Femoral Resurfacing ComponentBiopro, Inc. · 2005 · cites it directly1descendant
  • K070292Durom Hip Resurfacing System, Femoral ComponentsZimmer GmbH · 2007 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K983452Nelson Resurfacing HeadBiomet, Inc.1998—
−1K021799Cemented Femoral Head Resurfing DeviceBiomet Orthopedics, Inc.2002—
0 (this device)K032659Depuy Asr Resurfacing Femoral HeadsDePuy Orthopaedics, Inc.2003—
+1K043542Biopro Tara Femoral Resurfacing ComponentBiopro, Inc.2005—
+1K070292Durom Hip Resurfacing System, Femoral ComponentsZimmer GmbH20073

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
200710
FIG. 1 — Lineage of K032659, 1998–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KXA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KXA device

  1. #1 K201219 Biocore9 Femoral Head Resurfacing Componentscore 0.7 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.

TypeNumberDeviceApplicantDecidedRecalls
Kept off the family treeK810325DePuy T.A.R.A. Total Hip Prosthesis
Not in FDA’s 510(k), De Novo or PMA lists as we hold them (a misreading, a typo, or a number FDA does not list), so it is kept off the family tree
Summary page 1
…Class I! DEVICE PRODUCT CODE: 87 KXA SUBSTANTIALLY EQUIVALENT DePuy '.A.R.A Total Hip, K810325 DEVICES: Cemented Femoral Head Resurfacing Device…
*K021799Cemented Femoral Head Resurfing Device
Summary page 1
…K810325 DEVICES: Cemented Femoral Head Resurfacing Device (Biomet Orthopaedics, Inc.), K021799 DEVICE DESCRIPTION: The DePuy ASRTM Resurfacing Femoral Heads are designed for use in hemi-arthroplasty applications to replace…
Biomet Orthopedics, Inc.2002—

Also cleared against K021799: 2 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K043542Biopro Tara Femoral Resurfacing ComponentBiopro, Inc.20051
K070292Durom Hip Resurfacing System, Femoral ComponentsZimmer GmbH20070

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 23, 2010Not classifiedZ-1772-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1764-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1766-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1771-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1763-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1775-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1765-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1773-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1769-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1770-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1774-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1768-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1767-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 5 years and passes through 3 companies; a new generation was cleared every 3.6 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K043542 (Biopro, Inc., 2005) has gone furthest, with 1 descendant of its own.
  • 2 other devices also cite its predicate K021799.

How does its category compare?

All KXA devices

KXA Prosthesis, Hip, Femoral, Resurfacing: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KXA

1in 2021

2007: 22008: 12010: 12021: 1
2007high 2 (2007) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KXA

Too few KXA 510(k)s in any year since 2007 to give a median.

Recalls per year · KXA

1in 2012

2007: 22010: 132012: 1
2007high 13 (2010) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KXA

14in 2025

2007: 152008: 222009: 112010: 682011: 5932012: 2,0992013: 2,5222014: 2,4312015: 1,6742016: 6212017: 5802018: 4302019: 9712020: 3732021: 172022: 132023: 52024: 22025: 14
2007high 2,522 (2013) · low 2 (2024)2025

MAUDE reports naming product code KXA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—215
20081—022
20090—011
20101—1368
20110—0593
20120—12,099
20130—02,522
20140—02,431
20150—01,674
20160—0621
20170—0580
20180—0430
20190—0971
20200—0373
20211—017
20220—013
20230—05
20240—02
20250—014
20260—0—

What is it indicated for?

The DePuy ASRTM Resurfacing Femoral Heads are intended for cemented use in partial hip replacement procedures (hemi-arthroplasty). Indications are for patients suffering severe pain and disability due to osteoarthritis, rheumatoid arthritis, congenital hip dysplasia, post-traumatic arthritis, avascular necrosis, or slipped capital femoral epiphysis. Additional indications include other abnormalities where major pathology affects the femoral head; where the acetabular cavity is normal and not deformed or weakened; and where acetabular replacement is either not required or not desirable.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K032659: Depuy Asr Resurfacing Femoral Heads.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K032659

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026